scholarly article | Q13442814 |
P356 | DOI | 10.1002/MDS.10078 |
P698 | PubMed publication ID | 11835448 |
P50 | author | Jau-Shyong Hong | Q63384716 |
P2093 | author name string | Jack W Lipton | |
Dave A Gayle | |||
Paul M Carvey | |||
Chong Wai Tong | |||
Shang Yong Ma | |||
ZaoDung Ling | |||
P2860 | cites work | Differential fetal and maternal contributions to the cytokine milieu in a murine model of infection-induced preterm birth | Q78168590 |
Aetiology of Parkinson's disease | Q28261357 | ||
Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's disease | Q28324372 | ||
Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons | Q28511306 | ||
Could Parkinson's disease follow intra-uterine influenza?: a speculative hypothesis | Q33631298 | ||
Current evaluation and management of vulvovaginitis | Q33660444 | ||
Neuroinflammatory processes are important in neurodegenerative diseases: an hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease development | Q33669393 | ||
Redox regulation of TNF signaling | Q33803280 | ||
Parkinson's disease: pathophysiology | Q36495393 | ||
Compensatory mechanisms in degenerative neurologic diseases. Insights from parkinsonism | Q37686045 | ||
Parkinson's disease in twins: a follow-up study | Q38448503 | ||
CD14 and other recognition molecules for lipopolysaccharide: a review | Q40402783 | ||
Role of prostaglandins in mediating alterations in glucose metabolism during acute endotoxemia in the rat. | Q40686408 | ||
Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction | Q40962119 | ||
Partial purification of a pramipexole-induced trophic activity directed at dopamine neurons in ventral mesencephalic cultures | Q41033477 | ||
Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines | Q41059727 | ||
Midbrain dopaminergic neurons (nuclei A8, A9, and A10): three-dimensional reconstruction in the rat. | Q41079201 | ||
6-hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the rat. A possible mechanism for restoration of the nigrostriatal circuit mediated by glial cell line-derived neurotrophic factor | Q41170164 | ||
Does prepregnancy bacterial vaginosis increase a mother's risk of having a preterm infant with cerebral palsy? | Q41684601 | ||
Induction of dopaminergic neuron phenotype in the midbrain by Sonic hedgehog protein | Q42479348 | ||
Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons | Q42504503 | ||
Slow changes of tyrosine hydroxylase gene expression in dopaminergic brain neurons after neurotoxin lesioning: a model for neuron aging | Q43480259 | ||
Motor behavioural changes after intracerebroventricular injection of 6-hydroxydopamine in the rat: an animal model of Parkinson's disease | Q43564955 | ||
Administration of interleukin-1 at birth affects dopaminergic neurons in adult mice | Q47966803 | ||
Dopamine transporter-immunoreactive neurons decrease with age in the human substantia nigra | Q48189864 | ||
Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients | Q48191627 | ||
The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins | Q48216713 | ||
The magnitude of brain dopamine depletion from prenatal cocaine exposure is a function of uterine position | Q48414876 | ||
Cytokine regulation of embryonic rat dopamine and serotonin neuronal survival in vitro | Q48584015 | ||
Tyrosine hydroxylase-like (TH) immunoreactivity in Parkinson's disease and Alzheimer's disease | Q48594533 | ||
Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson's disease using disector counts | Q48616749 | ||
The time course of developmental cell death in phenotypically defined dopaminergic neurons of the substantia nigra | Q48797592 | ||
Unbiased morphometrical measurements show loss of pigmented nigral neurones with ageing. | Q52137725 | ||
Few microorganisms associated with bacterial vaginosis may constitute the pathologic core: a population-based microbiologic study among 3596 pregnant women. | Q52245653 | ||
Light-microscopic immunocytochemical localization of tyrosine hydroxylase in prenatal rat brain. I. Early ontogeny | Q52293274 | ||
Cytokine secretion by human fetal membranes, decidua and placenta at term | Q61415524 | ||
Association of oligohydramnios in women with preterm premature rupture of membranes with an inflammatory response in fetal, amniotic, and maternal compartments | Q61845615 | ||
Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. | Q67403760 | ||
Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | Q70951248 | ||
Inflammatory cytokine (interleukins 1, 6 and 8 and tumor necrosis factor-alpha) release from cultured human fetal membranes in response to endotoxic lipopolysaccharide mirrors amniotic fluid concentrations | Q71181808 | ||
Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures | Q71377883 | ||
MPTP-induced oxidative stress and neurotoxicity are age-dependent: evidence from measures of reactive oxygen species and striatal dopamine levels | Q72417927 | ||
Expression of inflammatory cytokines (interleukin-1 beta and interleukin-6) in amniochorionic membranes | Q72547092 | ||
Striatal trophic activity is reduced in the aged rat brain | Q73455130 | ||
Pramipexole attenuates the dopaminergic cell loss induced by intraventricular 6-hydroxydopamine | Q73881020 | ||
Chorioamnionitis reduces placental endocrine functions: the role of bacterial lipopolysaccharide and superoxide anion | Q74261164 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | endotoxins | Q319997 |
P304 | page(s) | 116-124 | |
P577 | publication date | 2002-01-01 | |
P1433 | published in | Movement Disorders | Q1486418 |
P1476 | title | In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain | |
P478 | volume | 17 |
Q36493835 | Alpha-Phenyl-n-tert-butyl-nitrone attenuates lipopolysaccharide-induced neuronal injury in the neonatal rat brain |
Q46684395 | Alpha-phenyl-n-tert-butyl-nitrone ameliorates hippocampal injury and improves learning and memory in juvenile rats following neonatal exposure to lipopolysaccharide |
Q35792836 | Altered glutathione homeostasis in animals prenatally exposed to lipopolysaccharide |
Q35046915 | An inflammatory review of Parkinson's disease. |
Q33390827 | Analysis of targeted mutation in DJ-1 on cellular function in primary astrocytes |
Q36924624 | Animal models of Parkinson's disease progression |
Q35813131 | Aspects of innate immunity and Parkinson's disease |
Q30391351 | Astaxanthin ameliorates prenatal LPS-exposed behavioral deficits and oxidative stress in adult offspring. |
Q28387937 | CNS infections, sepsis and risk of Parkinson's disease |
Q37213687 | Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein α-synuclein |
Q42726407 | Chronic dichlorvos exposure: microglial activation, proinflammatory cytokines and damage to nigrostriatal dopaminergic system |
Q34886336 | Cytokines and perinatal brain damage |
Q34748994 | Determination of immunoglobulin A against Gardnerella vaginalis hemolysin, sialidase, and prolidase activities in vaginal fluid: implications for adverse pregnancy outcomes |
Q36952358 | Developmental heptachlor exposure increases susceptibility of dopamine neurons to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)in a gender-specific manner. |
Q35639110 | Developmental neuropathology of environmental agents. |
Q28383196 | Developmental neurotoxicity: some old and new issues |
Q35611320 | Diesel exhaust activates and primes microglia: air pollution, neuroinflammation, and regulation of dopaminergic neurotoxicity |
Q27498993 | Does neuroinflammation fan the flame in neurodegenerative diseases? |
Q37251953 | Dopamine-dependent compensation maintains motor behavior in mice with developmental ablation of dopaminergic neurons. |
Q34510971 | Dopaminergic neuronal injury in the adult rat brain following neonatal exposure to lipopolysaccharide and the silent neurotoxicity. |
Q48435759 | Early life environment: does it have implications for predisposition to disease? |
Q35990909 | Early-Life Factors and Risk of Parkinson's Disease: A Register-Based Cohort Study |
Q42243282 | Effect of prenatal infection of mice with bacterial endotoxin on the migration of neurons producing gonadotropin-releasing hormone |
Q37338674 | Effects of Regular Treadmill Exercise on a DNA Oxidative-Damage Marker and Total Antioxidant Capacity in Rat Hippocampal Tissue. |
Q36133711 | Effects of prenatal immune activation and peri-adolescent stress on amphetamine-induced conditioned place preference in the rat. |
Q34516073 | Effects of two commonly found strains of influenza A virus on developing dopaminergic neurons, in relation to the pathophysiology of schizophrenia. |
Q37387824 | Endotoxin induces a delayed loss of TH-IR neurons in substantia nigra and motor behavioral deficits |
Q36721776 | Estrogen action in neuroprotection and brain inflammation. |
Q42112840 | Gastrodin inhibits neuroinflammation in rotenone-induced Parkinson's disease model rats |
Q28388674 | Gene-environment interactions: key to unraveling the mystery of Parkinson's disease |
Q48467010 | Hypoactivity of the central dopaminergic system and autistic-like behavior induced by a single early prenatal exposure to lipopolysaccharide |
Q41262976 | Immune responses in Parkinson's disease: interplay between central and peripheral immune systems |
Q40263168 | Infections as a risk factor for Parkinson's disease: a case-control study. |
Q36052641 | Inflammation as a causative factor in the aetiology of Parkinson's disease |
Q38040993 | Innate inflammation in Parkinson's disease |
Q36512406 | Interleukin-10 Protection against Lipopolysaccharide-Induced Neuro-Inflammation and Neurotoxicity in Ventral Mesencephalic Cultures |
Q38103856 | Interleukin-1β and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson's Disease? |
Q37217248 | Intrastriatal lipopolysaccharide injection induces parkinsonism in C57/B6 mice |
Q33508801 | Investigating bacterial sources of toxicity as an environmental contributor to dopaminergic neurodegeneration |
Q80678600 | MAC1 mediates LPS-induced production of superoxide by microglia: the role of pattern recognition receptors in dopaminergic neurotoxicity |
Q48062607 | Maternal Omega-3 Supplement Improves Dopaminergic System in Pre- and Postnatal Inflammation-Induced Neurotoxicity in Parkinson's Disease Model. |
Q35069372 | Maternal infection and white matter toxicity |
Q33548162 | Maternal inheritance and mitochondrial DNA variants in familial Parkinson's disease |
Q29547835 | Microglia-mediated neurotoxicity: uncovering the molecular mechanisms |
Q37794379 | Microglial activation and chronic neurodegeneration |
Q46567817 | Microglial cells and Parkinson's disease |
Q34037199 | Modeling a sensitization stage and a precipitation stage for Parkinson's disease using prenatal and postnatal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration |
Q36616362 | Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease |
Q36913314 | Neonatal exposure to lipopolysaccharide enhances accumulation of α-synuclein aggregation and dopamine transporter protein expression in the substantia nigra in responses to rotenone challenge in later life |
Q35255816 | Neonatal exposure to lipopolysaccharide enhances vulnerability of nigrostriatal dopaminergic neurons to rotenone neurotoxicity in later life |
Q37182878 | Neonatal systemic exposure to lipopolysaccharide enhances susceptibility of nigrostriatal dopaminergic neurons to rotenone neurotoxicity in later life |
Q33663970 | Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention |
Q42908536 | Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease |
Q36919403 | Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention |
Q35876266 | Oxidative stress and microglial cells in Parkinson's disease |
Q37097440 | PRENATAL INFECTION, MATERNAL IMMUNE ACTIVATION, AND RISK FOR SCHIZOPHRENIA. |
Q37679695 | Paraquat and Parkinson's disease |
Q24815148 | Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation |
Q42651923 | Parkinson's disease and systemic inflammation |
Q28084395 | Parkinson's disease as a result of aging |
Q39327711 | Parkinson's disease: Microglial/macrophage-induced immunoexcitotoxicity as a central mechanism of neurodegeneration |
Q46736932 | Pathological dynamics of activated microglia following medial forebrain bundle transection |
Q64934156 | Peli1 controls the survival of dopaminergic neurons through modulating microglia-mediated neuroinflammation. |
Q37607849 | Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance. |
Q34587666 | Prenatal LPS increases inflammation in the substantia nigra of Gdnf heterozygous mice |
Q38021432 | Prenatal and postnatal animal models of immune activation: relevance to a range of neurodevelopmental disorders |
Q36367080 | Prenatal exposure to methanol as a dopamine system sensitization model in C57BL/6J mice |
Q37116911 | Prevotella bivia as a source of lipopolysaccharide in the vagina |
Q36485934 | Progressive dopamine neuron loss in Parkinson's disease: the multiple hit hypothesis |
Q37336951 | Regulator of G-protein signaling 10 promotes dopaminergic neuron survival via regulation of the microglial inflammatory response |
Q28386323 | Role of early life exposure and environment on neurodegeneration: implications on brain disorders |
Q44323441 | Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease. |
Q24614960 | Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration |
Q48453030 | Temporal effects of paraquat/maneb on microglial activation and dopamine neuronal loss in older rats |
Q30466613 | The Long and the Short of it: Gene and Environment Interactions During Early Cortical Development and Consequences for Long-Term Neurological Disease |
Q39737653 | The degenerating substantia nigra as a susceptible region for gene transfer-mediated inflammation. |
Q34557246 | The endotoxin-induced neuroinflammation model of Parkinson's disease. |
Q35206992 | The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins? |
Q37076726 | The lipopolysaccharide Parkinson's disease animal model: mechanistic studies and drug discovery |
Q48794767 | The morphogenetic effect of bacterial endotoxin lipopolysaccharide on the functioning of the reproductive system in rats |
Q24815642 | The role of early life environmental risk factors in Parkinson disease: what is the evidence? |
Q45128097 | The role of glucose in brain injury following the combination of lipopolysaccharide or lipoteichoic acid and hypoxia-ischemia in neonatal rats |
Q36331560 | The role of inflammation in perinatal brain injury |
Q45076613 | Transient parkinsonism: induced by progesterone or pregnancy? |
Q46132067 | Updates on immunity and inflammation in Parkinson disease pathology |
Q88917772 | Withania somnifera as a Potential Anxiolytic and Anti-inflammatory Candidate Against Systemic Lipopolysaccharide-Induced Neuroinflammation |
Search more.